Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation

PHASE2CompletedINTERVENTIONAL
Enrollment

699

Participants

Timeline

Start Date

December 31, 1998

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2011

Conditions
Breast Cancer
Interventions
PROCEDURE

Sentinel Node Biopsy

Once the patient is asleep under anesthetic, they receive an intraoperative injection of 1.0 mCi of Technetium-99 sulfur colloid into normal breast tissue surrounding the primary cancer or biopsy cavity directed subareolar or around the tumor. This is followed by blue dye injected in the subareolar complex approximately 5 minutes prior to incision. The sentinel node biopsy is performed, followed by lumpectomy/mastectomy, and a completion axillary node dissection if the sentinel node(s) were positive.

Trial Locations (1)

72205

University of Arkansas For Medical Sciences, Little Rock

All Listed Sponsors
lead

University of Arkansas

OTHER

NCT00575744 - Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation | Biotech Hunter | Biotech Hunter